Supplemental Material: Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast Cancer

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.

Articles in this issue

---

Use of COTA Nodal Address Highlights Variance in Cancer Care Cost: An Interview With Donald M. Berwick, MD, MPP

Radiation Oncology’s Role in the Next Chapter of Payment Reform

ACCC and ASCO Collaborative Targets Disparities in Cancer Clinical Trials

Flying the Plane While You Build It

The Untapped Potential of Cell and Gene Therapy

Interview: Tanya Siddiqi, MD, Discusses the Promise of Reduced Toxicity With Liso-Cel

FDA Approves Osimertinib for Adjuvant Treatment of Early-Stage EGFR-Mutated NSCLC

Certain NSCLC Patients Are More Likely to Respond to Immunotherapy, Study Results Show

Possible Treatment Identified for Aggressive NSCLC Subset

Contributor: A Practical Path Forward to More Patient-Centered Value Assessment

Proximity to Treatment, Racial Disparities Are Seen in Ovarian Cancer Survival

Lung Cancer Screenings Fall, Biopsy Rates Rise During COVID-19

As Mammography Screenings Drop, Advanced Breast Cancer Cases Increase in First Months of COVID-19

Azacitidine Is Shown to Improve Overall, Relapse-Free Survival in Older Adults With AML

FDA Updates Ibrutinib Label With 5-Year Data in Waldenström Macroglobulinemia

Related Videos

Related Content

Advertisement

July 25th 2025

KFF Survey: Most Consumers Find Prior Authorization Is a Major Problem

Mary Caffrey

A new survey reveals widespread consumer frustration with prior authorization, highlighting the need for urgent reform in insurance coverage.

March 26th 2024

Exploring Medicare Advantage Prior Authorization Variations

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.

July 24th 2025

Prevalence and Inclusiveness of Pay-for-Performance Incentives for HPV Vaccination

Justin G. Trogdon, PhD Kathryn R. Brignole, MS Ben Fogel, MD, MPH Tara Licciardello Queen, PhD

This article examines the prevalence of pay-for-performance incentives to promote human papillomavirus vaccination and other quality metrics as reported by frontline clinical staff.

August 1st 2023

Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology

Maggie L. Shaw

Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."

July 23rd 2025

Effects of Adjunctive Cariprazine Formulary Restrictions in Major Depressive Disorder

Nadia Nabulsi, PhD François Laliberté, MA Enrico Zanardo, PhD Sean D. MacKnight, MScPH Sophie Ma, MSc Sally W. Wade, MPH Mousam Parikh, MSc

Patients who experienced a formulary-related rejection of cariprazine for adjunctive treatment of major depressive disorder had significantly higher hospitalization rates than those with approved claims.

July 22nd 2025

COA Welcomes Christine Pfaff, MBA, RPh, to Leadership Team

AJMC Staff

Christine Pfaff, MBA, RPh, joins COA as director of clinical initiatives, enhancing support for community oncology practices and pharmacy operations amid health care challenges.

Related Content

Advertisement

July 25th 2025

KFF Survey: Most Consumers Find Prior Authorization Is a Major Problem

Mary Caffrey

A new survey reveals widespread consumer frustration with prior authorization, highlighting the need for urgent reform in insurance coverage.

March 26th 2024

Exploring Medicare Advantage Prior Authorization Variations

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.

July 24th 2025

Prevalence and Inclusiveness of Pay-for-Performance Incentives for HPV Vaccination

Justin G. Trogdon, PhD Kathryn R. Brignole, MS Ben Fogel, MD, MPH Tara Licciardello Queen, PhD

This article examines the prevalence of pay-for-performance incentives to promote human papillomavirus vaccination and other quality metrics as reported by frontline clinical staff.

August 1st 2023

Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology

Maggie L. Shaw

Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."

July 23rd 2025

Effects of Adjunctive Cariprazine Formulary Restrictions in Major Depressive Disorder

Nadia Nabulsi, PhD François Laliberté, MA Enrico Zanardo, PhD Sean D. MacKnight, MScPH Sophie Ma, MSc Sally W. Wade, MPH Mousam Parikh, MSc

Patients who experienced a formulary-related rejection of cariprazine for adjunctive treatment of major depressive disorder had significantly higher hospitalization rates than those with approved claims.

July 22nd 2025

COA Welcomes Christine Pfaff, MBA, RPh, to Leadership Team

AJMC Staff

Christine Pfaff, MBA, RPh, joins COA as director of clinical initiatives, enhancing support for community oncology practices and pharmacy operations amid health care challenges.